$999 Million is the total value of Soleus Capital Management, L.P.'s 68 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 69.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRput | $144,652,000 | – | 1,292,000 | +100.0% | 14.48% | – |
| IWM | New | ISHARES TRput | $113,116,000 | – | 508,500 | +100.0% | 11.32% | – |
| LNTH | Buy | LANTHEUS HLDGS INC | $50,980,000 | +61.4% | 1,764,627 | +43.5% | 5.10% | +3.7% |
| EPIX | Buy | ESSA PHARMA INC | $50,061,000 | +118.2% | 3,525,457 | +22.9% | 5.01% | +40.2% |
| BCAB | BIOATLA INC | $49,378,000 | -33.3% | 2,515,424 | 0.0% | 4.94% | -57.2% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $35,502,000 | +88.9% | 164,300 | +61.4% | 3.55% | +21.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $27,878,000 | +45.3% | 478,596 | +49.8% | 2.79% | -6.6% |
| SRDX | Buy | SURMODICS INC | $25,652,000 | +20.9% | 532,757 | +39.6% | 2.57% | -22.3% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $23,801,000 | +129.7% | 318,275 | +74.5% | 2.38% | +47.6% |
| THTX | Buy | THERATECHNOLOGIES INC | $23,307,000 | -18.4% | 7,692,082 | +1.0% | 2.33% | -47.5% |
| NPCE | Buy | NEUROPACE INC | $23,275,000 | -12.1% | 2,309,003 | +38.3% | 2.33% | -43.5% |
| FGEN | New | FIBROGEN INC | $21,862,000 | – | 1,550,497 | +100.0% | 2.19% | – |
| NRIX | Buy | NURIX THERAPEUTICS INC | $21,517,000 | +172.2% | 743,238 | +181.6% | 2.15% | +74.8% |
| NTRA | Buy | NATERA INC | $21,255,000 | +37.2% | 227,599 | +63.8% | 2.13% | -11.8% |
| IRMD | Sell | IRADIMED CORP | $20,796,000 | +37.4% | 450,030 | -0.1% | 2.08% | -11.7% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $20,537,000 | – | 593,200 | +100.0% | 2.06% | – |
| Sell | DICE THERAPEUTICS INC | $20,525,000 | -28.8% | 810,940 | -7.8% | 2.06% | -54.2% | |
| APEN | New | APOLLO ENDOSURGERY INC | $19,348,000 | – | 2,295,100 | +100.0% | 1.94% | – |
| EDAP | Buy | EDAP TMS S Asponsored adr | $18,860,000 | -0.0% | 3,148,609 | +6.5% | 1.89% | -35.8% |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $18,472,000 | +102.7% | 1,999,087 | +212.4% | 1.85% | +30.2% |
| CCCC | Sell | C4 THERAPEUTICS INC | $18,068,000 | -46.1% | 561,122 | -25.2% | 1.81% | -65.4% |
| ISEE | Sell | IVERIC BIO INC | $17,863,000 | +0.6% | 1,068,376 | -2.3% | 1.79% | -35.4% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $15,979,000 | +143.8% | 228,437 | +82.0% | 1.60% | +56.7% |
| CVS | New | CVS HEALTH CORP | $14,236,000 | – | 138,000 | +100.0% | 1.42% | – |
| ANGO | Buy | ANGIODYNAMICS INC | $14,216,000 | +126.0% | 515,450 | +112.5% | 1.42% | +45.2% |
| STE | New | STERIS PLC | $12,682,000 | – | 52,100 | +100.0% | 1.27% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $11,840,000 | +259.2% | 378,997 | +75.7% | 1.18% | +130.5% |
| CVRX | Buy | CVRX INC | $11,767,000 | +14.9% | 962,165 | +55.4% | 1.18% | -26.2% |
| EOLS | Buy | EVOLUS INC | $8,195,000 | +67.3% | 1,258,889 | +95.8% | 0.82% | +7.5% |
| New | XILIO THERAPEUTICS INC | $7,640,000 | – | 477,495 | +100.0% | 0.76% | – | |
| PCVX | Sell | VAXCYTE INC | $7,012,000 | -22.3% | 294,750 | -17.1% | 0.70% | -50.1% |
| SIEN | Sell | SIENTRA INC | $6,943,000 | -49.2% | 1,891,878 | -20.7% | 0.70% | -67.4% |
| INSP | Sell | INSPIRE MED SYS INC | $6,315,000 | -12.4% | 27,450 | -11.3% | 0.63% | -43.7% |
| BVS | Buy | BIOVENTUS INC | $6,207,000 | +363.2% | 428,397 | +352.8% | 0.62% | +197.1% |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $6,113,000 | +65.4% | 101,600 | +53.9% | 0.61% | +6.2% |
| GLPG | Sell | GALAPAGOS NVspon adr | $5,447,000 | -10.2% | 98,800 | -14.3% | 0.54% | -42.3% |
| CARA | New | CARA THERAPEUTICS INC | $5,203,000 | – | 427,200 | +100.0% | 0.52% | – |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $5,033,000 | -33.6% | 310,494 | +16.9% | 0.50% | -57.4% |
| KDNY | New | CHINOOK THERAPEUTICS INC | $4,872,000 | – | 298,700 | +100.0% | 0.49% | – |
| BAX | New | BAXTER INTL INC | $4,378,000 | – | 51,000 | +100.0% | 0.44% | – |
| New | IO BIOTECH INC | $4,305,000 | – | 672,734 | +100.0% | 0.43% | – | |
| DXCM | New | DEXCOM INC | $4,166,000 | – | 7,759 | +100.0% | 0.42% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $4,028,000 | +39.0% | 338,760 | +89.9% | 0.40% | -10.6% |
| ABBV | New | ABBVIE INC | $3,724,000 | – | 27,500 | +100.0% | 0.37% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $3,718,000 | +9.9% | 40,000 | -29.6% | 0.37% | -29.4% |
| CUTR | Buy | CUTERA INC | $3,561,000 | +427.6% | 86,180 | +495.2% | 0.36% | +240.0% |
| DA32 LIFE SCNCE TEC ACQSTN C | $3,434,000 | -0.2% | 350,000 | 0.0% | 0.34% | -35.8% | ||
| VSTM | New | VERASTEM INC | $3,371,000 | – | 1,644,500 | +100.0% | 0.34% | – |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $2,975,000 | -1.3% | 300,000 | 0.0% | 0.30% | -36.6% | |
| ZGNX | Buy | ZOGENIX INC | $2,846,000 | +9.6% | 175,152 | +2.4% | 0.28% | -29.6% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $2,598,000 | -32.1% | 687,412 | -7.1% | 0.26% | -56.4% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $2,490,000 | -51.3% | 158,700 | -46.9% | 0.25% | -68.8% |
| CCXI | New | CHEMOCENTRYX INC | $2,488,000 | – | 68,320 | +100.0% | 0.25% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $1,779,000 | – | 90,000 | +100.0% | 0.18% | – |
| IMUX | New | IMMUNIC INC | $1,675,000 | – | 175,000 | +100.0% | 0.17% | – |
| NVCR | Sell | NOVOCURE LTD | $1,672,000 | -47.2% | 22,275 | -18.3% | 0.17% | -66.2% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $1,667,000 | -83.9% | 22,000 | -76.1% | 0.17% | -89.6% |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $1,443,000 | -47.0% | 1,950,000 | 0.0% | 0.14% | -66.1% | ||
| New | AVALO THERAPEUTICS INC | $1,309,000 | – | 770,000 | +100.0% | 0.13% | – | |
| LQDA | New | LIQUIDIA CORPORATION | $1,127,000 | – | 231,485 | +100.0% | 0.11% | – |
| ARVN | New | ARVINAS INC | $904,000 | – | 11,000 | +100.0% | 0.09% | – |
| HOWL | Sell | WEREWOLF THERAPEUTICS INC | $769,000 | -92.0% | 64,585 | -88.5% | 0.08% | -94.9% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $624,000 | – | 10,250 | +100.0% | 0.06% | – |
| FATE | New | FATE THERAPEUTICS INC | $456,000 | – | 7,800 | +100.0% | 0.05% | – |
| CELC | Sell | CELCUITY INC | $423,000 | -71.9% | 32,073 | -61.7% | 0.04% | -82.1% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $227,000 | -66.1% | 2,850 | -63.0% | 0.02% | -77.9% |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $230,000 | -73.3% | 13,000 | -68.3% | 0.02% | -82.8% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $44,000 | -97.8% | 10,000 | -95.4% | 0.00% | -98.7% |
| EWTX | Exit | EDGEWISE THERAPEUTICS INC | $0 | – | -31,300 | -100.0% | -0.08% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.09% | – |
| RFL | Exit | RAFAEL HLDGS INC | $0 | – | -21,742 | -100.0% | -0.10% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -20,000 | -100.0% | -0.12% | – | |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -23,500 | -100.0% | -0.15% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -112,499 | -100.0% | -0.16% | – | |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -261,050 | -100.0% | -0.21% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -213,519 | -100.0% | -0.22% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -158,140 | -100.0% | -0.39% | – |
| CDMO | Exit | AVID BIOSERVICES INC | $0 | – | -135,000 | -100.0% | -0.45% | – |
| CORT | Exit | CORCEPT THERAPEUTICS INC | $0 | – | -155,000 | -100.0% | -0.48% | – |
| VIVO | Exit | MERIDIAN BIOSCIENCE INC | $0 | – | -163,000 | -100.0% | -0.49% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -87,612 | -100.0% | -0.49% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -120,900 | -100.0% | -0.51% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -97,979 | -100.0% | -0.51% | – |
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -127,743 | -100.0% | -0.60% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -1,122,000 | -100.0% | -0.61% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -117,600 | -100.0% | -0.64% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -210,815 | -100.0% | -0.80% | – |
| Exit | SOMALOGIC INC | $0 | – | -422,243 | -100.0% | -0.82% | – | |
| SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -201,994 | -100.0% | -0.82% | – |
| ITMR | Exit | ITAMAR MED LTDsponsored ads | $0 | – | -180,839 | -100.0% | -0.85% | – |
| CTSO | Exit | CYTOSORBENTS CORP | $0 | – | -800,000 | -100.0% | -1.01% | – |
| CDNA | Exit | CAREDX INC | $0 | – | -126,661 | -100.0% | -1.25% | – |
| Exit | GOSSAMER BIO INCnote 5.000% 6/0 | $0 | – | -8,200,000 | -100.0% | -1.31% | – | |
| NEO | Exit | NEOGENOMICS INC | $0 | – | -190,556 | -100.0% | -1.43% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -2,084,050 | -100.0% | -1.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.